Abstract：
BACKGROUND: Submaximal field walking tests are easy to apply and low cost, but it is necessary to standardize their application, especially in the pediatric population. The feasibility and its use in patients with congenital heart disease have been studied. To verify which are the submaximal field walking tests applied in the cardiopulmonary assessment of children and adolescents with CHD and to verify if they are being performed as recommended by the standardization protocols/guidelines.
METHODS: Literature review through a search in six electronic databases, structured in PICO format, without date restrictions. Looking for studies that used submaximal field walking tests in children and adolescents with congenital heart disease aged 5 to 18 years. Methodological quality, effectiveness and safety and risk of bias were assessed.
RESULTS: Five studies met the eligibility criteria with a sample of 160 individuals with congenital heart disease, and all used the six-minute walk test. Note that different methodologies and modifications are used. Only the clinical trial showed good methodological quality.Four studies had low risk of bias and one study had moderate risk.
CONCLUSIONS: Although the six-minute walk test is the only test used as a field test found in our research, there is no standardization in the application of the test, making it difficult to compare the results. In this sense, reducing the limitations and heterogeneity in the application of the test will enable more concrete outcomes and facilitate their reproduction in clinical practice.
METHODS: Literature review through a search in six electronic databases, structured in PICO format, without date restrictions. Looking for studies that used submaximal field walking tests in children and adolescents with congenital heart disease aged 5 to 18 years. Methodological quality, effectiveness and safety and risk of bias were assessed.
RESULTS: Five studies met the eligibility criteria with a sample of 160 individuals with congenital heart disease, and all used the six-minute walk test. Note that different methodologies and modifications are used. Only the clinical trial showed good methodological quality.Four studies had low risk of bias and one study had moderate risk.
CONCLUSIONS: Although the six-minute walk test is the only test used as a field test found in our research, there is no standardization in the application of the test, making it difficult to compare the results. In this sense, reducing the limitations and heterogeneity in the application of the test will enable more concrete outcomes and facilitate their reproduction in clinical practice.
摘要：
背景：次最大野外步行测试易于应用且成本低，但是有必要标准化它们的应用，尤其是在儿科人群中。已经研究了其在先天性心脏病患者中的可行性及其使用。验证哪些是用于CHD儿童和青少年心肺评估的次最大野外步行测试，并验证它们是否按照标准化方案/指南的建议进行。
方法：通过在六个电子数据库中搜索的文献综述，以PICO格式构造，没有日期限制。寻找在5至18岁患有先天性心脏病的儿童和青少年中使用次最大野外步行测试的研究。方法学质量,评估了有效性,安全性和偏倚风险.
结果：五项研究符合资格标准，样本为160例先天性心脏病患者，都用了六分钟步行测试.注意,使用不同的方法和修改。只有临床试验显示出良好的方法学质量。四项研究的偏倚风险较低，一项研究的偏倚风险中等。
结论：尽管六分钟步行测试是我们研究中发现的唯一用作现场测试的测试，测试的应用没有标准化，很难比较结果。在这个意义上,减少试验应用中的局限性和异质性将获得更具体的结果，并促进其在临床实践中的复制。
方法：通过在六个电子数据库中搜索的文献综述，以PICO格式构造，没有日期限制。寻找在5至18岁患有先天性心脏病的儿童和青少年中使用次最大野外步行测试的研究。方法学质量,评估了有效性,安全性和偏倚风险.
结果：五项研究符合资格标准，样本为160例先天性心脏病患者，都用了六分钟步行测试.注意,使用不同的方法和修改。只有临床试验显示出良好的方法学质量。四项研究的偏倚风险较低，一项研究的偏倚风险中等。
结论：尽管六分钟步行测试是我们研究中发现的唯一用作现场测试的测试，测试的应用没有标准化，很难比较结果。在这个意义上,减少试验应用中的局限性和异质性将获得更具体的结果，并促进其在临床实践中的复制。
